HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+18.87%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$137M
AUM Growth
+$137M
(+14%)
Cap. Flow
+$1.97M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34
Top Buys
Top Sells
| 1 |
TECD
Tech Data Corp
TECD
|
$7.91M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
$4.15M |
| 3 |
LOGM
LogMein, Inc.
LOGM
|
$2.89M |
| 4 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$548K |
| 5 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$505K |
Sector Composition
| 1 | Technology | 36.76% |
| 2 | Healthcare | 21.07% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Communication Services | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Avidity Biosciences
RNA
$6.12B
| $484K | 0.35% |
+17,202
| New | +$484K |
|
52
Crinetics Pharmaceuticals
CRNX
$3.26B
| $483K | 0.35% |
30,845
+5,144
| +20% | +$80.6K |
|
53
Geron
GERN
$893M
| $482K | 0.35% |
+277,080
| New | +$482K |
|
54
Xenon Pharmaceuticals
XENE
$2.99B
| $482K | 0.35% |
43,517
+23,278
| +115% | +$258K |
|
55
Relmada Therapeutics
RLMD
$48.8M
| $473K | 0.34% |
12,565
+2,872
| +30% | +$108K |
|
56
Neurogene
NGNE
$284M
| $471K | 0.34% |
39,234
+10,682
| +37% | +$128K |
|
57
Amicus Therapeutics
FOLD
$2.42B
| $464K | 0.34% |
32,893
+6,030
| +22% | +$85.1K |
|
58
MacroGenics
MGNX
$121M
| $457K | 0.33% |
+18,144
| New | +$457K |
|
|
DRNA
59
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $448K | 0.33% |
24,920
+3,719
| +18% | +$66.9K |
|
60
Prothena Corp
PRTA
$452M
| $444K | 0.32% |
+44,414
| New | +$444K |
|
|
ADAP
61
Adaptimmune Therapeutics
ADAP
$13.9M
| $443K | 0.32% |
+55,479
| New | +$443K |
|
62
Assembly Biosciences
ASMB
$183M
| $439K | 0.32% |
+26,691
| New | +$439K |
|
63
Axsome Therapeutics
AXSM
$6.09B
| $428K | 0.31% |
6,012
-929
| -13% | -$66.1K |
|
|
GBT
64
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $416K | 0.3% |
7,549
+1,288
| +21% | +$71K |
|
|
CNST
65
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $398K | 0.29% |
19,664
+4,776
| +32% | +$96.7K |
|
66
Rocket Pharmaceuticals
RCKT
$358M
| $396K | 0.29% |
17,342
-7,682
| -31% | -$175K |
|
67
Adverum Biotechnologies
ADVM
$68.2M
| $369K | 0.27% |
35,798
+9,600
| +37% | +$99K |
|
|
ZGNX
68
DELISTED
Zogenix, Inc.
ZGNX
| $349K | 0.25% |
19,492
+4,275
| +28% | +$76.5K |
|
|
AVDL
69
Avadel Pharmaceuticals
AVDL
$1.42B
| $290K | 0.21% |
57,495
+6,087
| +12% | +$30.7K |
|
70
Check Point Software Technologies
CHKP
$20.6B
| $241K | 0.18% |
2,000
-800
| -29% | -$96.4K |
|
|
SRNE
71
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $201K | 0.15% |
+18,000
| New | +$201K |
|
72
QuinStreet
QNST
$875M
| $196K | 0.14% |
12,400
| – | – |
|
73
UBS Group
UBS
$126B
| $155K | 0.11% |
+15,080
| New | +$155K |
|
74
TrueCar
TRUE
$183M
| $149K | 0.11% |
+29,700
| New | +$149K |
|
75
Vera Bradley
VRA
$58.7M
| $141K | 0.1% |
+23,100
| New | +$141K |
|